Home/Cambium Oncology/Giovanni Selvaggi, MD
GS

Giovanni Selvaggi, MD

Chief Medical Officer and Director

Cambium Oncology

Therapeutic Areas

Cambium Oncology Pipeline

DrugIndicationPhase
CAMV-01 (Small Molecule)Cancer (VIP/VPAC high)Pre-clinical
ANT308CancerPre-clinical
CART-ANT308Pancreatic Cancer / Solid TumorsPre-clinical
Fc-ANT308CancerPre-clinical